The nature of the principal Type 1 interferon-producing cells in human blood

Science

Volumn 284, Issue 5421, 1999, Pages 1835-1837

  Siegal, Frederick P ^a,e   Kadowaki, Norimitsu ^b   Shodell, Michael ^c   Fitzgerald Bocarsly, Patricia A ^d   Shah, Kokila ^a,e   Ho, Stephen ^b   Antonenko, Svetlana ^b   Liu, Yong Jun ^b  

^a ST VINCENT S HOSPITAL   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c LONG ISLAND UNIVERSITY   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD4 ANTIGEN; GLYCOPROTEIN P 15095; INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL ISOLATION; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; PRIORITY JOURNAL; PROTEIN DETERMINATION; APOPTOSIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INTERFERON PRODUCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; PROTEIN EXPRESSION; STEM CELL; T LYMPHOCYTE SUBPOPULATION;

CD40 LIGAND; CELL LINEAGE; CELL SEPARATION; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; INTERFERON TYPE I; INTERFERON-ALPHA; INTERFERON-BETA; INTERLEUKIN-3; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; ORGANELLES; RNA, MESSENGER; SIMPLEXVIRUS; STEM CELLS;

EID: 0033546053     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.284.5421.1835     Document Type: Article

References (30)

1. A. Isaacs and J. Lindemann, Proc. R. Soc. London 147, 258 (1957).
2. P. Fitzgerald-Bocarsly, Pharmacol. Ther. 60, 39 (1993).
3. H. Kirchner et al., Immunobiology 156, 65 (1979).
4. H. H. Peter et al., Eur. J. Immunol. 10, 547 (1980).
5. J. Abb, H. Abb, F. Deinhart, Clin. Exp. Immunol. 52, 179 (1983).
6. B. Perussia, V. Fanning, C. Trinchieri, Nat. Immun. Cell Growth Regul. 4, 120 (1985).
7. J. Chehimi et al., Immunology 68, 488 (1989).
8. K. Sandberg et al., Scand. J. Immunol. 34, 565 (1991).
9. S. E. Starr et al., Adv. Exp. Med. Biol. 329, 173 (1993).
10. H. Svensson et al., Scand J. Immunol. 44, 164 (1996).
11. S. B. Feldman et al., Virology 204, 1 (1994).
12. M. Feldman and P. Fitzgerald-Bocarsly, J. Interferon Res. 10, 435 (1990).
13. J. J. Ferbas et al., J. Immunol. 152, 4649 (1994); S. B. Feldman et al., J. Leukocyte Biol. 57, 214 (1995).
14. J. J. Ferbas et al., J. Immunol. 152, 4649 (1994); S. B. Feldman et al., J. Leukocyte Biol. 57, 214 (1995).
15. S. Ghanekar et al., J. Immunol. 157, 4028 (1996).
16. C. Lopez, P. Fitzgerald, F. P. Siegal. J. Infect. Dis. 148, 962 (1983); D. M. Howell, S. B. Feldman, P. Kloser, P. Fitzgerald-Bocarsly, Clin. Immunol. Immunopathol. 7, 223 (1994); J. Ferbas, J. Navratil, A. Logar, C. Rinaldo, Clin. Diagn. Lab. Immunol. 2, 138 (1995).
17. C. Lopez, P. Fitzgerald, F. P. Siegal. J. Infect. Dis. 148, 962 (1983); D. M. Howell, S. B. Feldman, P. Kloser, P. Fitzgerald-Bocarsly, Clin. Immunol. Immunopathol. 7, 223 (1994); J. Ferbas, J. Navratil, A. Logar, C. Rinaldo, Clin. Diagn. Lab. Immunol. 2, 138 (1995).
18. C. Lopez, P. Fitzgerald, F. P. Siegal. J. Infect. Dis. 148, 962 (1983); D. M. Howell, S. B. Feldman, P. Kloser, P. Fitzgerald-Bocarsly, Clin. Immunol. Immunopathol. 7, 223 (1994); J. Ferbas, J. Navratil, A. Logar, C. Rinaldo, Clin. Diagn. Lab. Immunol. 2, 138 (1995).
19. F. P. Siegal et al., J. Clin. Invest. 78, 115 (1986).
20. U. O'Doherty et al., J. Exp. Med. 178, 1067 (1993).
21. U. O'Doherty et al., Immunology 82, 487 (1994).
22. G. Grouard et al., J. Exp. Med. 185, 1101 (1997).
23. J. Olweus et al., Proc. Natl. Acad. Sci. U.S.A. 94, 12551 (1997).
24. M.-C. Rissoan et al., Science 283, 1183 (1999).
25. 4 plaque-forming units of virus in 96-well culture plates) (23). IFN in supematants from 24-hour cultures with and without IL-3 were analyzed with cytopathic reduction in human foreskin fibroblast monolayers cultured with vesicular stomatitis virus (sensitivity, 2 to 25 IU of IFN per milliliter) (23). Cytocentrifuge preparations of cells from 6-hour cultures were prepared for IFN-α immunostaining with mouse monoclonal antibody 7N4-1 (10 μg/ml; Schering-Plough Research Institute, Kenilworth, NJ) (21). Cells from 6-hour cultures were centrifuged and the sediment frozen for IFN-α and IFN-β mRNA PCR analyses (24).
26. F. P. Siegal et al., Leukemia 8, 1474 (1994).
27. 32P-labeted probes.
28. S. Sun et al., J. Exp. Med. 188, 2335 (1998).
29. P. Marrack et al., ibid. 189, 521 (1999).
30. We thank T. L Nagabhushan, L. L. Lanier, H. Kanzler, D. Imperato, C. Lopez, L. Filgueira, G. Grouard, and R. Rai for continued support. F.P.S. is supported by a grant from Pharmacia and Upjohn. DNAX Research Institute of Molecular and Cellular Biology is supported by Schering-Plough Corporation.